Yellowstone Partners’s Bristol-Myers Squibb BMY Stock Holding History

Yellowstone Partners’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$287K	Buy	5,314 +402	+8%	+$25.8K	0.11%	171
2016 Q2	$361K	Buy	4,912 +1,047	+27%	+$74K	0.16%	123
2016 Q1	$247K	Buy	3,865 +467	+14%	+$29.5K	0.11%	161
2015 Q4	$234K	Buy	+3,398	New	+$225K	0.11%	159
2015 Q3	–	Sell	-3,009	Closed	-$200K	–	221
2015 Q2	$200K	Sell	3,009 -381	-11%	-$25.1K	0.09%	185
2015 Q1	$219K	Sell	3,390 -336	-9%	-$21K	0.11%	158
2014 Q4	$220K	Buy	+3,726	New	+$210K	0.12%	152

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Yellowstone Partners's BMY Position: Q3 2016 in Review

Yellowstone Partners increased its Bristol-Myers Squibb (BMY) stake by 8.2% in Q3 2016, buying an estimated $25.8K and bringing the position to 5,314 shares worth $287K. The position accounts for 0.11% of the portfolio, ranked #171.

Yellowstone Partners first reported a position in BMY in Q4 2014 and has held it in 7 quarters since. The position peaked at $361K in Q2 2016. 1,522 funds tracked by Wall St. Rank hold BMY as of Q3 2016.

Yellowstone Partners held 5,314 shares of Bristol-Myers Squibb worth $287K as of Q3 2016.
Yellowstone Partners bought 402 Bristol-Myers Squibb shares in Q3 2016, an estimated $25.8K.
Bristol-Myers Squibb made up 0.11% of Yellowstone Partners's portfolio in Q3 2016, its #171 holding.
Yellowstone Partners first reported a position in Bristol-Myers Squibb in Q4 2014 and has held it in 7 quarters since.
Yellowstone Partners's Bristol-Myers Squibb position peaked at $361K in Q2 2016.
1,522 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2016.

Based on Yellowstone Partners's 13F filing for Q3 2016, filed 27 Oct 2016.